glp-1 news updates november 2025 ISPOR 2025: Exploring reasons for discontinuation glp-1 news november 2025 Novo

Description

Weekly Injection Semaglutide Vial Physician-guided plan Medication included Ongoing support Free shipping to Texas Weekly Injection Tirzepatide Vial Dual GLP-1 + GIP action Medication included Ongoing support Free shipping to Texas Weekly Semaglutide Pen Wegovy Injection FDA-approved semaglutide Prior auth support Ongoing clinical oversight Free shipping to Texas Weekly Tirzepatide Pen Zepbound FDA-approved tirzepatide Prior auth support Ongoing clinical oversight Free shipping to Texas All plans include physician oversight

The injection site map remembers where you injected last and helps rotate sites without writing it on a paper calendar

doi: 10.2337/dci23-0048

Prior efforts to treat obesity demonstrate that sustained weight reduction is a Herculean task--thus it may be the case that GLP-1 agents will need to be administered chronically to sustain anti-obesity benefits